Unprecedented experimental finding
Researchers from the Spanish National Cancer Research Centre (CNIO) have presented a study in Madrid showing how a therapy based on three inhibitor drugs induces complete and lasting regression of pancreatic ductal adenocarcinoma —the most common and aggressive type of pancreatic cancer— in genetically modified mice, without significant side effects and with a response that lasted...
